Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Givastomig by I-Mab for Solid Tumor: Likelihood of Approval
Givastomig is under clinical development by I-Mab and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
Data Insights
Givastomig by I-Mab for Gastric Cancer: Likelihood of Approval
Givastomig is under clinical development by I-Mab and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...